Literature DB >> 17124383

Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease.

Rajiv Agarwal1, Martin J Andersen.   

Abstract

BACKGROUND: Blood pressure (BP) measured outside the clinic correlates better with cardiovascular outcomes in patients with essential hypertension. To assess the role of out-of-clinic BP recordings in predicting cardiovascular events in patients with chronic kidney disease (CKD), a prospective cohort study was conducted in 217 veterans with CKD.
METHODS: BP was measured outside the clinic at home and by 24-hour ambulatory recordings, and in the clinic by 'routine' and standardized methods. Patients were followed over a median of 3.4 years to assess the combined end-point of total mortality, myocardial infarction or stroke.
RESULTS: Average (+/-SD) home BP was 147.0 +/- 21.4/78.3 +/- 11.6 mm Hg, 24-hour ambulatory BP 133.5 +/- 16.6/73.1 +/- 11.1 mm Hg and in-clinic BPs were 155.2 +/- 25.6/84.7 +/- 14.2 mm Hg by the standardized method, and 144.5 +/- 24.2/75.4 +/- 14.7 mm Hg by the 'routine' method. A 1 SD increase in systolic BP increased the hazard ratio (HR) of the composite end-point by 1.16 (95% CI 0.89-1.50) for routine BP, 1.57 (95% CI 1.19-2.09) for standardized BP, 1.66 (95% CI 1.27-2.17) for home BP, and 1.42 (95% CI 1.10-1.84) for 24-hour ambulatory BP recording. The HR of the composite end-point was only significant for hypertension defined by 24-hour ambulatory BP monitoring (HR 2.22 (95% CI 1.23-4.01)). Adjusted for the propensity scores, BP measured by the ambulatory technique was not an independent predictor of cardiovascular events. Non-dipping was associated with increased cardiovascular risk, but not when adjusted for other risk factors.
CONCLUSION: Risk factors that differentiate hypertension or non-dipping appear to confer a cardiovascular risk in CKD. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 17124383     DOI: 10.1159/000097366

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  38 in total

1.  BP Components in Advanced CKD and the Competing Risks of Death, ESRD, and Cardiovascular Events.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

Review 2.  Chronotherapy improves blood pressure control and reduces vascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; Artemio Mojón; José R Fernández; Juan J Crespo; Ana Moyá; María T Ríos; Francesco Portaluppi
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

3.  Much to Fear about MUCH.

Authors:  Rajiv Agarwal
Journal:  J Am Soc Nephrol       Date:  2020-10-06       Impact factor: 10.121

4.  Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study.

Authors:  Li-Yan Wang; Dao-Xin Yin; Dong-Liang Zhang; Rui Xu; Wen-Ying Cui; Wen-Hu Liu
Journal:  Int Urol Nephrol       Date:  2012-12-07       Impact factor: 2.370

Review 5.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

6.  Clinical implications of ambulatory and home blood pressure monitoring.

Authors:  Soon-Gil Kim
Journal:  Korean Circ J       Date:  2010-09-30       Impact factor: 3.243

Review 7.  Ambulatory blood pressure in chronic kidney disease.

Authors:  Debbie L Cohen; Yonghong Huan; Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 8.  Management of hypertension in chronic kidney disease.

Authors:  Raymond R Townsend; Sandra J Taler
Journal:  Nat Rev Nephrol       Date:  2015-07-28       Impact factor: 28.314

Review 9.  Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

Review 10.  Ambulatory blood pressure and cardiovascular risk in chronic kidney disease.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.